Radiotherapy effects on the ceRNA network in high-risk prostate cancer patients
The ceRNA network monitoring might be emerging as a valuable tool for assessing treatment responses. However, future studies with larger cohorts are needed to validate these results.
Authors
- Sahar Naderinasab
- Nooshin Ahmadirad (ORCID: https://orcid.org/0000-0001-9853-8180)
- Somayeh Sadani (ORCID: https://orcid.org/0000-0002-1909-9616)
- Vahid Khori (ORCID: https://orcid.org/0000-0002-4672-9732)
- Solmaz Khalighfard (ORCID: https://orcid.org/0000-0003-2111-8342)
- Amirhoushang Poorkhani
- Ali Mohammad Alizadeh (ORCID: https://orcid.org/0009-0005-4886-8081)
- Zahra Akbari (ORCID: https://orcid.org/0000-0003-0978-588X)
Institutions
- Iran University of Medical Sciences (IR)
- Golestan University of Medical Sciences (IR)
- Iranian Center for Quantum Technologies (IR)
- Bushehr University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-10-03
- DOI
- https://doi.org/10.5603/rpor.107762
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tehran University of Medical Sciences and Health Services
- Golestan University of Medical Sciences